Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chang-Ming Huang

44PUBLICATIONS
36CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

Sort by Publication Date:
|Apr 22, 2026
Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances anti-PD-1 efficacy in gastric cancer.

|Apr 14, 2026
<i>Tff2</i> marks gastric corpus progenitors that give rise to pyloric metaplasia/SPEM following injury.

Ruhong Tu, Hua-Long Zheng, Biyun Zheng

|Apr 16, 2025
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics.

You-Xin Gao, Xiao-Jing Guo, Bin Lin

|Mar 07, 2025
Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.

Guang-Tan Lin, Cheng Yan, Lu-Jie Li

|Feb 12, 2025
Preoperative visceral fat area predicts intraoperative adverse events during lymphadenectomy in laparoscopic gastrectomy for gastric cancer: a post hoc analysis.

Ling-Hua Wei, Hua-Long Zheng, Zhi-Yu Liu

|Jul 12, 2024
Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway.

Mi Lin, Ru-Hong Tu, Sheng-Ze Wu

Pageof 8

Frequent Collaborators

18 joint publications

Chao-Hui Zheng

11 joint publications

Ru-Hong Tu

4 joint publications

Long-Long Cao

3 joint publications

Qi-Yue Chen

3 joint publications

Jian-Wei Xie

2 joint publications

Jian-Xian Lin

2 joint publications

Ru-Hong Tu

2 joint publications

Qing Zhong

1 joint publications

Alexander Zaika

1 joint publications

Hiroki Kobayashi

Frequent Collaborators

18 joint publications

Chao-Hui Zheng

11 joint publications

Ru-Hong Tu

4 joint publications

Long-Long Cao

3 joint publications

Qi-Yue Chen

Top Related Videos

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on : May 02, 2022

2.0K
Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on : May 07, 2018

11.0K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

3.9K
See more related videos

Top Related Videos

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on : May 02, 2022

2.0K
Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on : May 07, 2018

11.0K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

3.9K
See more related videos